SHIRE EXTENDS FOSRENOL PROGRAM

Published Online: Sunday, April 1, 2007

Follow Pharmacy_Times:

In an effort to help seniors impacted by the "doughnut hole," Shire Pharmaceuticals is launching a new
Medicare Part D component under the Fosrenol (lanthanum carbonate) At Hand Patient Assistance
Program.

Shire provides help to patients who have no coverage for Fosrenol under prescription drug benefits,
Medicare, Medicaid, or other state-funded programs, by providing the drug free of charge or at a shared
(reduced) cost. Now, qualifying patients enrolled in a Medicare Part D program who cannot afford their
copayments or coinsurance, along with those facing the doughnut-hole coverage gap, may receive the
drug at no cost. Patients will receive a monthly supply of Fosrenol through the end of the calendar year
in which they enroll in the program.

Fosrenol is indicated to reduce serum phosphate in patients with end-stage renal disease. For more
information about the program, call 866-325-8223.